company background image
530199 logo

Themis Medicare BSE:530199 Stock Report

Last Price

₹222.35

Market Cap

₹20.5b

7D

7.8%

1Y

95.9%

Updated

27 Mar, 2024

Data

Company Financials

Themis Medicare Limited

BSE:530199 Stock Report

Market Cap: ₹20.5b

530199 Stock Overview

Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally.

530199 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance2/6
Financial Health5/6
Dividends1/6

Rewards

Risk Analysis

No risks detected for 530199 from our risk checks.

Themis Medicare Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Themis Medicare
Historical stock prices
Current Share Price₹222.35
52 Week High₹266.00
52 Week Low₹109.00
Beta0.61
1 Month Change-9.24%
3 Month Change7.49%
1 Year Change95.88%
3 Year Change693.26%
5 Year Change679.77%
Change since IPO10,029.84%

Recent News & Updates

Recent updates

Shareholder Returns

530199IN PharmaceuticalsIN Market
7D7.8%2.7%2.5%
1Y95.9%63.9%47.3%

Return vs Industry: 530199 exceeded the Indian Pharmaceuticals industry which returned 65% over the past year.

Return vs Market: 530199 exceeded the Indian Market which returned 48.6% over the past year.

Price Volatility

Is 530199's price volatile compared to industry and market?
530199 volatility
530199 Average Weekly Movement7.1%
Pharmaceuticals Industry Average Movement5.9%
Market Average Movement6.6%
10% most volatile stocks in IN Market10.1%
10% least volatile stocks in IN Market4.0%

Stable Share Price: 530199 has not had significant price volatility in the past 3 months.

Volatility Over Time: 530199's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1952996Sachin Patelhttps://www.themismedicare.com

Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients (APIs) and formulations for use in various therapeutic areas, including anti-tuberculosis, anti-malarials, cardiology, pain management, anti-infectives, haematinics, health and nutrition, anaesthesia, gynecology, and orthopedics, as well as non-steroidal anti-inflammatory drugs. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001.

Themis Medicare Limited Fundamentals Summary

How do Themis Medicare's earnings and revenue compare to its market cap?
530199 fundamental statistics
Market cap₹20.47b
Earnings (TTM)₹452.86m
Revenue (TTM)₹3.64b

45.2x

P/E Ratio

5.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
530199 income statement (TTM)
Revenue₹3.64b
Cost of Revenue₹1.28b
Gross Profit₹2.36b
Other Expenses₹1.91b
Earnings₹452.86m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 30, 2024

Earnings per share (EPS)4.92
Gross Margin64.89%
Net Profit Margin12.44%
Debt/Equity Ratio26.0%

How did 530199 perform over the long term?

See historical performance and comparison

Dividends

0.2%

Current Dividend Yield

9%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.